Implementing evidence-based patient and family education on oral anticoagulation therapy: a community-based participatory project

Journal of Clinical Nursing
Maya ShahaLuzia Herrmann

Abstract

This study aimed at developing and implementing evidence-based patient and family education on oral anticoagulation therapy. The number of persons with chronic diseases who live at home is increasing. They have to manage multiple diseases and complex treatments. One such treatment is oral anticoagulation therapy, a high risk variable dose medication. Adherence to oral anticoagulation therapy is jeopardised by limited information about the medications, their risk and complications, the impact of individual daily routine and the limited inclusion of family members in education. Hence, improved and tailored education is essential for patients and families to manage oral anticoagulation therapy at home. A community-based participatory research design combined with the Precede-Proceed model was used including a systematic literature review, posteducation analysis, an online nurse survey, a documentation analysis and patient/family interviews. The study was conducted between April 2010-December 2012 at a department of general internal medicine in a teaching hospital in Switzerland. Participants were the department's nursing and medical professionals including the patients and their families. The evidence-based patient and family educ...Continue Reading

References

Jun 5, 1998·Annual Review of Public Health·B A IsraelA B Becker
May 26, 2004·Public Health Reports·Halsted Holman, Kate Lorig
Jul 21, 2004·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Amy D WatermanBrian F Gage
Sep 20, 2005·Contemporary Nurse·Anthony G Tuckett
Nov 25, 2005·Pharmacotherapy·Ian A Orensky, David A Holdford
Jun 8, 2006·Geriatric Nursing·Brenda Bergman-Evans
Oct 19, 2007·Patient Education and Counseling·Kathleen M MazorJerry H Gurwitz
Dec 6, 2007·Journal of General Internal Medicine·Mary Ann SevickRobert M Goodman
Nov 23, 2007·Joint Commission Journal on Quality and Patient Safety·Edward L MachtingerDean Schillinger
Feb 14, 2008·Pharmacoepidemiology and Drug Safety·Alec B PlattStephen E Kimmel
Jul 24, 2008·Journal of Cancer Survivorship : Research and Practice·Eugene J LengerichElana Farace
Jan 14, 2009·Journal of Clinical Pharmacy and Therapeutics·F RyanS O'Shea
Jul 7, 2009·International Journal of Behavioral Medicine·Dean G CruessStephen E Kimmel
Nov 17, 2009·Medizinische Klinik·Edgar A Mueller, Wilhelm Kirch
Dec 25, 2009·Circulation. Cardiovascular Quality and Outcomes·Adam J RoseElaine M Hylek
Jun 24, 2010·The Annals of Pharmacotherapy·Amanda R McFee WinansDarren Triller
May 7, 2011·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Jessica C WellmanMichael B Streiff
Mar 21, 2012·BMC Public Health·Calypse B AgborsangayaJeffrey A Johnson
Jan 11, 2013·The Journal of the Association of Nurses in AIDS Care : JANAC·Joachim G Voss
Feb 21, 2013·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Rupert A PayneStewart W Mercer
Sep 4, 2013·Clinical Research in Cardiology : Official Journal of the German Cardiac Society·Sebastian EwenUlrich Laufs
Oct 31, 2013·Journal of the American Association of Nurse Practitioners·Melissa KrampsArlene Smaldone

❮ Previous
Next ❯

Citations

May 31, 2019·Medicine·Josiane Moreira da CostaMaria Auxiliadora Parreiras Martins

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.